June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
The Role of the STING/Type I IFN Signaling Pathway in Age-Related Macular Degeneration(AMD)
Author Affiliations & Notes
  • Chao Huang
    Roche Pharma Research and Early Development, Ophthalmology Discovery, Roche Innovation Center Basel, F Hoffmann-La Roche AG Research and Development Division, Basel, Basel-Stadt, Switzerland
  • Gabriella Widmer
    Roche Pharma Research and Early Development, Ophthalmology Discovery, Roche Innovation Center Basel, F Hoffmann-La Roche AG Research and Development Division, Basel, Basel-Stadt, Switzerland
  • Pamela Strassburger
    Roche Pharma Research and Early Development, Ophthalmology Discovery, Roche Innovation Center Basel, F Hoffmann-La Roche AG Research and Development Division, Basel, Basel-Stadt, Switzerland
  • Mirjana Lazendic
    Roche Pharma Research and Early Development, Ophthalmology Discovery, Roche Innovation Center Basel, F Hoffmann-La Roche AG Research and Development Division, Basel, Basel-Stadt, Switzerland
  • Sabine Gruener
    Roche Pharma Research and Early Development, Ophthalmology Discovery, Roche Innovation Center Basel, F Hoffmann-La Roche AG Research and Development Division, Basel, Basel-Stadt, Switzerland
  • Haitao Liu
    Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States
  • Alan Proia
    Pathology, Duke University Medical Center, Durham, North Carolina, United States
  • Eleonora Lad
    Ophthalmology, Duke University Medical Center, Durham, North Carolina, United States
  • Peter Westenskow
    Roche Pharma Research and Early Development, Ophthalmology Discovery, Roche Innovation Center Basel, F Hoffmann-La Roche AG Research and Development Division, Basel, Basel-Stadt, Switzerland
  • Nikolaos Mitrousis
    Roche Pharma Research and Early Development, Ophthalmology Discovery, Roche Innovation Center Basel, F Hoffmann-La Roche AG Research and Development Division, Basel, Basel-Stadt, Switzerland
  • Debasish Sinha
    Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States
    Johns Hopkins Medicine Wilmer Eye Institute, Baltimore, Maryland, United States
  • Derrick Feenstra
    Roche Pharma Research and Early Development, Ophthalmology Discovery, Roche Innovation Center Basel, F Hoffmann-La Roche AG Research and Development Division, Basel, Basel-Stadt, Switzerland
  • Footnotes
    Commercial Relationships   Chao Huang F. Hoffmann-La Roche AG, Code E (Employment); Gabriella Widmer F. Hoffmann-La Roche AG, Code E (Employment); Pamela Strassburger F. Hoffmann-La Roche AG, Code E (Employment); Mirjana Lazendic F. Hoffmann-La Roche AG, Code E (Employment); Sabine Gruener F. Hoffmann-La Roche AG, Code E (Employment); Haitao Liu F. Hoffmann-La Roche AG, Code F (Financial Support); Alan Proia F. Hoffmann-La Roche AG, Code F (Financial Support); Eleonora Lad F. Hoffmann-La Roche AG, Code F (Financial Support); Peter Westenskow F. Hoffmann-La Roche AG, Code E (Employment); Nikolaos Mitrousis F. Hoffmann-La Roche AG, Code E (Employment); Debasish Sinha F. Hoffmann-La Roche AG, Code F (Financial Support); Derrick Feenstra F. Hoffmann-La Roche AG, Code E (Employment)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 4598 – F0390. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Chao Huang, Gabriella Widmer, Pamela Strassburger, Mirjana Lazendic, Sabine Gruener, Haitao Liu, Alan Proia, Eleonora Lad, Peter Westenskow, Nikolaos Mitrousis, Debasish Sinha, Derrick Feenstra; The Role of the STING/Type I IFN Signaling Pathway in Age-Related Macular Degeneration(AMD). Invest. Ophthalmol. Vis. Sci. 2022;63(7):4598 – F0390.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Geographic atrophy(GA), an advanced form of age-related macular degeneration(AMD), is characterized by degeneration of the photoreceptors and retinal pigment epithelium(RPE). Prior evidence has implicated senescent retinal cells contribute to the pathogenesis of AMD. Increased activation of cyclic GMP–AMP synthase(cGAS)/ stimulator of interferon genes(STING)/Type I Interferon pathway has been reported in GA patients. However, the role of Type-I IFNβ in chronic retinal degeneration remains elusive. This study aims to investigate the role of STING/IFNβ in chronic retinal degeneration and cellular senescence contributing to the pathogenesis of GA.

Methods : STING protein expression in postmortem eyes with various stages of AMD was measured by immunohistochemistry. Luminex was used to determine the IFNβ production in response to STING agonists in primary human RPEs. To elucidate the role of IFNβ in chronic retinal degeneration in vivo, AAV2-CAG-IFNβ(1x10^9 GC/eye, n=12) was used for chronic(20 weeks) expression of IFNβ in the eyes of C57BL/6J mice via intravitreal injection and AAV2-CAG-Null(1x10^9 GC/eye, n= 12) was injected as a control. Optical coherence tomography(OCT) and fluorescein angiography(FA) imaging were performed to monitor leakage and retinal degeneration. Senescence-associated(SA) β-galactosidase assay and immunohistochemistry were used to analyze the retinal cellular senescence and RPE degeneration.

Results : STING protein expression increased in the RPE of AMD patients. In primary human RPEs, STING agonists led to dose-dependent IFNβ production. In the mouse model, an increase of retinal degeneration was observed in AAV2-CAG-IFNβ injected eyes by OCT and fundus imaging, but not in AAV2-CAG-Null injected eyes. AAV2-CAG-IFNβ injected mouse eyes showed a reduction of RPE65 and CRALBP expression and developed degenerated RPEs with features remarkably similar to GA patients. Furthermore, β-galactosidase and p16INK4a positive retinal cells were upregulated in the murine eyes injected with AAV2-CAG-IFNβ, but not in the AAV2-CAG-Null eyes.

Conclusions : STING activation in RPE occurs in postmortem eyes with all stages of AMD. STING agonists drive IFNβ secretion in primary human RPEs. In the murine model, chronic IFNβ expression by AAV2 increases retinal cell senescence and contributes to RPE degeneration. These results suggest that cGAS/STING induced IFNβ may contribute to the pathogenesis of AMD.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×